Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: the X-ACT trialJ Cassidy, L. Garrison, S Jelić et al.|British Journal of Cancer|2006Cited by 125
A phase II open label, randomised study of ipilimumab with temozolomide versus temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblastoma: the Ipi-Glio trial protocolNicholas F. Brown, Paul Mulholland, Stasya Ng et al.|BMC Cancer|2020Cited by 51
Germline and Somatic Genetic Variants in the p53 Pathway Interact to Affect Cancer Risk, Progression, and Drug ResponsePing Zhang, Gareth L. Bond, Isaac Kitchen-Smith et al.|Cancer Research|2021Cited by 49
Germline and somatic genetic variants in the p53 pathway interact to affect cancer risk, progression and drug responsePing Zhang, Gareth L. Bond, Isaac Kitchen-Smith et al.|bioRxiv (Cold Spring Harbor Laboratory)|2019Cited by 10